FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017675802> ?p ?o ?g. }

• W2017675802 endingPage "825" @default.
• W2017675802 startingPage "817" @default.
• W2017675802 abstract "Glypican-3 is a membrane-bound proteoglycan whose expression has been linked to malignancies through the existence of both mutations and aberrant protein expression. Reports on glypican-3 expression in lung cancer were limited, with some evidence for loss of expression, which suggested a tumor-suppressor role. We sought to evaluate glypican-3 expression in lung cancer at the protein and mRNA levels and correlate it with clinical, histological and genomic characteristics such as RAS mutation status. We used immunohistochemistry on tissue microarray to study glypican-3 expression in 97 patients, evaluated glypican-3 mRNA levels by quantitative polymerase chain reaction in 143 patients and identified RAS mutations by allele-specific oligonucleotide hybridization. We correlated the results with clinical and histological data. Glypican-3 immunostaining was negative in all normal lung tissues, but positive in 23% of lung carcinoma samples. High protein and mRNA expression was associated with squamous histology (positive stain in 55% of squamous cell carcinoma vs 8% of adenocarcinoma, P<0.0001 for both immunostaining and mRNA). RAS mutations were highly associated with adenocarcinoma and low glypican-3 mRNA expression (P<0.0001 for both). Among smokers, glypican-3 mRNA expression was reduced in adenocarcinoma patients (P=0.013), and was elevated in those with squamous cell carcinoma (P=0.03, interaction P=0.0009). These opposing associations also correlated with the smoking burden. Patients with tumors staining positively for glypican-3 smoked significantly more than patients with tumors staining negatively (P=0.013). No association was found between glypican-3 expression and patient outcome. In conclusion, glypican-3 was overexpressed in cancerous compared with normal lung tissue. Adenocarcinoma and squamous cell carcinoma had differential expression of glypican-3, with predilection to squamous cell carcinoma patients who smoked. Glypican-3 expression in squamous cell carcinoma as an oncofetal protein renders it a potential candidate marker for early detection of lung squamous cell carcinoma." @default.
• W2017675802 created "2016-06-24" @default.
• W2017675802 creator A5001062703 @default.
• W2017675802 creator A5006711579 @default.
• W2017675802 creator A5016959101 @default.
• W2017675802 creator A5031467567 @default.
• W2017675802 creator A5040651513 @default.
• W2017675802 creator A5073362806 @default.
• W2017675802 creator A5090540894 @default.
• W2017675802 date "2008-07-01" @default.
• W2017675802 modified "2023-10-17" @default.
• W2017675802 title "Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma" @default.
• W2017675802 cites W1965612162 @default.
• W2017675802 cites W1972462861 @default.
• W2017675802 cites W1974350437 @default.
• W2017675802 cites W1976801200 @default.
• W2017675802 cites W1977543422 @default.
• W2017675802 cites W1986664280 @default.
• W2017675802 cites W1986826580 @default.
• W2017675802 cites W1988078905 @default.
• W2017675802 cites W1997828131 @default.
• W2017675802 cites W2000771269 @default.
• W2017675802 cites W2008581828 @default.
• W2017675802 cites W2009572702 @default.
• W2017675802 cites W2030485399 @default.
• W2017675802 cites W2033266412 @default.
• W2017675802 cites W2046937149 @default.
• W2017675802 cites W2049388096 @default.
• W2017675802 cites W2056621404 @default.
• W2017675802 cites W2058284416 @default.
• W2017675802 cites W2060322741 @default.
• W2017675802 cites W2067526335 @default.
• W2017675802 cites W2097413644 @default.
• W2017675802 cites W2106285087 @default.
• W2017675802 cites W2115328346 @default.
• W2017675802 cites W2118282497 @default.
• W2017675802 cites W2126014520 @default.
• W2017675802 cites W2126330431 @default.
• W2017675802 cites W2127758256 @default.
• W2017675802 cites W2130487816 @default.
• W2017675802 cites W2133040355 @default.
• W2017675802 cites W2153201655 @default.
• W2017675802 cites W2165222588 @default.
• W2017675802 cites W2170369650 @default.
• W2017675802 cites W2322558359 @default.
• W2017675802 cites W4210271223 @default.
• W2017675802 cites W4297745080 @default.
• W2017675802 doi "https://doi.org/10.1038/modpathol.2008.37" @default.
• W2017675802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18469798" @default.
• W2017675802 hasPublicationYear "2008" @default.
• W2017675802 type Work @default.
• W2017675802 sameAs 2017675802 @default.
• W2017675802 citedByCount "88" @default.
• W2017675802 countsByYear W20176758022012 @default.
• W2017675802 countsByYear W20176758022013 @default.
• W2017675802 countsByYear W20176758022014 @default.
• W2017675802 countsByYear W20176758022015 @default.
• W2017675802 countsByYear W20176758022016 @default.
• W2017675802 countsByYear W20176758022017 @default.
• W2017675802 countsByYear W20176758022018 @default.
• W2017675802 countsByYear W20176758022019 @default.
• W2017675802 countsByYear W20176758022020 @default.
• W2017675802 countsByYear W20176758022021 @default.
• W2017675802 countsByYear W20176758022022 @default.
• W2017675802 countsByYear W20176758022023 @default.
• W2017675802 crossrefType "journal-article" @default.
• W2017675802 hasAuthorship W2017675802A5001062703 @default.
• W2017675802 hasAuthorship W2017675802A5006711579 @default.
• W2017675802 hasAuthorship W2017675802A5016959101 @default.
• W2017675802 hasAuthorship W2017675802A5031467567 @default.
• W2017675802 hasAuthorship W2017675802A5040651513 @default.
• W2017675802 hasAuthorship W2017675802A5073362806 @default.
• W2017675802 hasAuthorship W2017675802A5090540894 @default.
• W2017675802 hasBestOaLocation W20176758021 @default.
• W2017675802 hasConcept C121608353 @default.
• W2017675802 hasConcept C126322002 @default.
• W2017675802 hasConcept C142724271 @default.
• W2017675802 hasConcept C193270364 @default.
• W2017675802 hasConcept C204232928 @default.
• W2017675802 hasConcept C2776256026 @default.
• W2017675802 hasConcept C2779742787 @default.
• W2017675802 hasConcept C2781182431 @default.
• W2017675802 hasConcept C2781294515 @default.
• W2017675802 hasConcept C4224716 @default.
• W2017675802 hasConcept C502942594 @default.
• W2017675802 hasConcept C71924100 @default.
• W2017675802 hasConcept C74864618 @default.
• W2017675802 hasConcept C86803240 @default.
• W2017675802 hasConceptScore W2017675802C121608353 @default.
• W2017675802 hasConceptScore W2017675802C126322002 @default.
• W2017675802 hasConceptScore W2017675802C142724271 @default.
• W2017675802 hasConceptScore W2017675802C193270364 @default.
• W2017675802 hasConceptScore W2017675802C204232928 @default.
• W2017675802 hasConceptScore W2017675802C2776256026 @default.
• W2017675802 hasConceptScore W2017675802C2779742787 @default.
• W2017675802 hasConceptScore W2017675802C2781182431 @default.
• W2017675802 hasConceptScore W2017675802C2781294515 @default.
• W2017675802 hasConceptScore W2017675802C4224716 @default.

• next